title: Atypical antipsychotic drugs upregulate synapsin II in the prefrontal cortex of post-mortem samples obtained from patients with schizophrenia.
authors.forename: Kelly A
authors.initials: KA
authors.lastname: Guest
authors.forename: Bailee A
authors.initials: BA
authors.lastname: Dyck
authors.forename: Shazli
authors.initials: S
authors.lastname: Shethwala
authors.forename: Ram K
authors.initials: RK
authors.lastname: Mishra
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014150:Antipsychotic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011180:Postmortem Changes; D017397:Prefrontal Cortex / Q000187:drug effects* / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D012559:Schizophrenia / Q000188:drug therapy / Q000473:pathology*; D016704:Synapsins / Q000235:genetics / Q000378:metabolism*; D015854:Up-Regulation / Q000187:drug effects*
chemical_list: D014150:Antipsychotic Agents; D012333:RNA, Messenger; D016704:Synapsins